Trade Mark Journal No.2026/038 18 September 2026

WO0000001935385 (5,42)

Office of origin: United States of America

Date of International Registration:17 June 2026
Date of designation in the UK: 17 June 2026
Image for mark 1935385

The mark consists of the word "GENESIS" above the words "MOLECULAR AI." The "I" in "GENESIS" has a star above it and to the left of the words are two interlocked cylinders.

MOLECULAR AI

International priority date claimed: 18 December 2025 (United States of America) (99555600)
Class 5
Pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of rare autoimmune and immune-system-related diseases and disorders; all of the foregoing excluding preparations for the treatment of ocular and opthalmic diseases and disorders.
Class 42
Pharmaceutical research and development; providing an online non-downloadable software platform for pharmaceutical research and development.

Genesis Molecular AI, Inc.

Representative: Emilia F. Cannella Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston MA 02199, UNITED STATES OF AMERICA